PIN1 and cancer: This interaction subsequently inhibits intracellular Pin1 activity and the proliferation of different cancer cell lines, including HeLa and BT-474, whilst also elevating the levels of PML and SMRT (silencing mediator for retinoic acid and thyroid hormone receptors) (77).